WallStreetZenWallStreetZen

NASDAQ: PBLS
Parabilis Medicines Inc Earnings Dates, Reports, Calls

OverviewEarnings
RevenueDividendOwnership
Parabilis Medicines earnings were N/A for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. The latest PBLS earnings report on Mar 31, 2026 announced Q1 2026 earnings of -$70.9M, down N/A from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, PBLS reported annual earnings of -$186.9M, with 15.8% growth.

PBLS earnings history

Current Revenue
$0.0
Current Earnings
$0.0
Current Profit Margin
0%

PBLS Return on Equity

Insufficient data to display

PBLS Return on Assets

Insufficient data to display

Be the first to know when PBLS announces earnings.

PBLS Return on Capital Employed

Current Company
0%
Current Industry
-9.5%

PBLS vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
AAPG-$160.60M-$182.22MN/A-$2.05
ABVC-$7.88M-$8.63MN/A-$0.39
ADAG-$16.85M-$17.61MN/A-$0.38
ADMA$221.54M$165.35M-21.59%$0.69
PBLSN/AN/AN/AN/A
View Top Biotech Stocks

Parabilis Medicines Earnings Reports & History FAQ

What were Parabilis Medicines's earnings last quarter?

Parabilis Medicines (NASDAQ: PBLS) reported Q1 2026 earnings per share (EPS) of -$34.58, up 45.05% year over year. Total PBLS earnings for the quarter were -$70.88 million. In the same quarter last year, Parabilis Medicines's earnings per share (EPS) was -$23.84.

If you're new to stock investing, here's how to buy Parabilis Medicines stock.

Is Parabilis Medicines profitable or losing money?

As of the last Parabilis Medicines earnings report, Parabilis Medicines is currently losing money. Parabilis Medicines's net profit (also called net income) for the twelve months ending Mar 31, 2026 was N/A, a N/A decrease year over year.

What was PBLS's earnings growth in the past year?

As of Parabilis Medicines's earnings date in Q2 2026, Parabilis Medicines's earnings has grown year over year. PBLS earnings in the past year totalled N/A.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.